Immunization of mice with the GP46/M-2 membrane glycoprotein has been demonstrated to elicit protection against infection with the parasitic protozoan Leishmania amazonensis. As this molecule is important for future vaccine studies of leishmaniasis, the gene encoding the 
GP46/M-2 surface membrane glycoprotein of Leishmania amazonensis has been cloned and sequenced. The protein sequence derived from the DNA sequence data is consistent with the known biochemical and immunochemical properties of the protein and indicates a number of structural areas of interest. A repetitive sequence (24 amino acids repeated four times) occurs within the amino-terminal portion ofthe molecule and constitutes --22% of the total mature protein. The protease-resistant immunodominant carboxyl-terminal domain of the protein comprises approximately half of the molecule and consists of proline-rich and cysteine-rich areas of sequence; the distribution of cysteine residues is suggestive of metal binding motifs. The sequence predicts a hydrophobic leader peptide, and a putative attachment site for a glycosyl-phosphatidylinositol anchor is indicated at the carboxyl terminus, consistent with the membrane location of the protein. Southern blot analyses also indicate the presence of a GP46/M-2 gene family.
Leishmania is a genus of parasitic protozoa capable of causing a spectrum of human disease (1, 2). Chemotherapeutic measures to control leishmanial infection can be difficult and are not always effective (3) . However, vaccination, at least against the cutaneous forms of leishmaniasis, is possible (4) . For centuries, vaccination with living organisms that produce a lesion has been practiced in the Middle East and has been the basis for vaccination programs in Israel and the U.S.S.R. However, complications that occur with the live vaccine (4) indicate the need for an attenuated or defined vaccine for cutaneous leishmaniasis. Studies of purified leishmanial antigenic components have resulted in significant protection using a murine model system (5) (6) (7) (8) .
Our laboratory has been focused on the identification of protective antigens for members of the Leishmania mexicana complex. Species of the L. mexicana complex have a wide geographical distribution, including South and Central America, the West Indies, and the southern United States (9) (10) (11) (12) . The parasites of this complex can cause cutaneous and diffuse cutaneous leishmaniasis. Diffuse cutaneous leishmaniasis, caused primarily by Leishmania amazonensis and Leishmania pifanoi, in a fraction of infected individuals (10) , is characterized by disseminated large histocytoma-like nodules containing numerous parasites and by deficient cellmediated immunity that may be associated with immunological suppression (12) (13) (14) . In general, these cases are resistant to chemotherapy (12) . Studies (8) in this laboratory using a murine model system indicate that a 46-kDa membrane glycoprotein of L. amazonensis (GP46/M-2) can be used to elicit a protective immune response against infection in susceptible mice. Using the amino-terminal sequence data derived from the purified protein, we have generated probes for, cloned, and sequenced the GP46/M-2 gene from L.
amazonensis.1 MATERIALS AND METHODS
Leishmania. L. amazonensis, strain LTBOO16 (MHOM/ BR/77/LTBOO16) was cultured in Schneider's Drosophila medium containing fetal bovine serum as described (15) .
Protein Isolation and Amino-Terminal Sequence Analyses. The GP46/M-2 protein was isolated from membrane preparations of L. amazonensis, strain LTBOO16 (MHOM/BR/77/ LTB0016), as described (8, 16) . The purification ofGP46/M-2 was monitored by polyacrylamide gel electrophoresis (17) and visualized by Coomassie brilliant blue staining. The protein sequence of the M-2 protein was determined in the presence of Brij 97H detergent by M. Margolis (Massachusetts General Hospital, Boston).
Pulse-Chase Metabolic Labeling Experiments. Logarithmic-phase L. amazonensis promastigotes were metabolically labeled for 2 hr using [35Sjmethionine (Amersham) and methionine-free Schneider's Drosophila medium as described (16) . The organisms were washed and then placed in complete Schneider's medium for the various periods of chase. The mRNA, used for translation experiments, was isolated using the guanidinium isothiocyanate method (18) and translated using the rabbit reticulocyte system (19) (Amersham) and [35S]methionine. Immunoprecipitation was performed as described (16) using either the M-2 monoclonal antibody, a negative control, Leishmania panamensis-specific monoclonal antibody (B-11) or, for the mRNA translation products, a rabbit heteroserum (16) raised to the purified GP46/M-2 protein.
EMBL3 Library Construction and Screening. L. amazonensis high molecular weight genomic DNA was isolated as described (20) $The sequence reported in this paper has been deposited in the GenBank data base (accession no. M38368).
8393
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
filters were hybridized with a 62-base oligonucleotide that was synthesized, at the Yale Oligonucleotide Synthesis Center, under the direction of D. Crothers, on the basis of the amino-terminal amino acid sequence (21, 22) of the purified GP46/M-2 protein (see Results and Discussion). Hybridizations with the 32P-labeled 62-mer were performed using 6x SSC/0.5% SDS/5 x Denhardt's solution/salmon sperm DNA (100 ,ug/ml)/10 mM EDTA at 450C (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0; lx Denhardt's solution = 0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02% bovine serum albumin). Washes were done in 2x SSC/0.5% SDS at 600C. A strongly hybridizing clone (7A12) was isolated and the DNA insert was mapped with restriction enzymes. A 2.7-kb BamHI fragment containing the entire coding region of GP46/M-2 and some flanking sequence was subcloned into pUC19 (p3BF16).
Southern and Northern Blot Analyses. For Southern blot hybridizations, DNA was subjected to electrophoresis in 0.8% agarose gels, blotted onto Nytran filters (Schleicher & Schuell), and analyzed as described (23, 24) . Hybridization of Southern blots was performed either as described above for the 62-base oligonucleotide or using a nick-translated 32P-labeled BamHI-Sph I internal DNA fragment from the cloned gene at 620C using 2x SSC/0.5% SDS, as described (22, 24) .
The filters were air-dried and exposed to Kodak X-Omat AR film at -70'C with Cronex Lightning Plus intensifier screens.
Northern blot analysis was performed using total mRNA isolated using the phenol/guanidinium isothiocyanate method (18) . mRNA was fractionated electrophoretically on 1.2% agarose gels containing 2.2 M formaldehyde (23) using RNA molecular markers (Bethesda Research Laboratories) as standards. Blots were probed with the 32P-labeled plasmid p3BF16 at 500C in 2x SSC/0.5% SDS, washed at 65°C using 2x SSC/0.5% SDS, and processed for radioautography as described above.
DNA Sequencing and Analysis. The 2.7-kb BamHI fragment from p3BF16 was subcloned in both orientations into M13mpl9 or into pBluescript (Stratagene). A set of overlapping deletions of plasmids containing inserts in either orientation for both strands of the fragment were generated by either the method of Dale et al. (25) using the Cyclone cloning system (International Biotechnologies) or the method of Henikoff (26) using the Erase-a-Base, system (Promega Biotec) and sequenced by a modified Sanger dideoxynucleotide chain-termination method (27) Amino-Terminal Protein Sequence. The amino-terminal sequence of the isolated and purified GP46/M-2 protein was determined. The protein sequence derived was Ala-Gly-ThrSer-Asp-Phe-Thr-Glu-Ala-Gln-Gln-Thr-Asn-Thr-Leu-ThrVal-Leu-Gln-Ala-Phe-Ala-Arg-Ala-Ile-Pro-Ala-Leu-Gly-. The sequence from Phe-6 through Pro-26 was used to design a 62-base oligonucleotide probe, based on the considerations of Lathe (21) and the codon usage and G/C bias in the third codon position reported for other Leishmania genes (22) . The sequence chosen for the oligonucleotide was 5'-TTCACG-GAGGCGCAGCAGACGAACACGCTGACGGTGCTG-CAGGCGTTCGCGCGCGCGATCCC-3'.
DNA Sequence Analysis of the GP46/M-2 Gene. The gene encoding the GP46/M-2 protein was cloned. Fig. 2B shows the restriction map of a 20-kb insert in EMBL3 clone 7A12 that contains two copies of the gene encoding the GP46/M-2 protein. A 2.7-kb BamHI fragment containing GP46/M-2 gene A was subcloned into pUC19 (p3BF16); a partial restriction enzyme digest map of p3BF16 is shown (Fig. 2B) . The coding region (1431 base pairs) is represented by the solid area with the ATG start codon beginning 70 base pairs from the BamHI site on the 5' end of the fragment.
The codon usage in the third position was 77% G/C, consistent with that found for other sequenced Leishmania genes (22) . No significant protein sequence identity/ similarity was found between GP46/M-2 and other sequenced molecules using the GenBank and EMBL data bases accessed through the University of Wisconsin Genetics Computer Group programs (28) . Fig. 2A displays the entire nucleotide and amino acid sequences of GP46/M-2A and also indicates some of the coding region restriction enzyme sites, as illustrated for p3BF16 (Fig. 2B) . The sequence derived from direct protein sequencing (data presented above) and that predicted from the genomic DNA sequence are in agreement for 27 out of 29 residues. The exceptions were the prediction from the DNAderived sequence of glycine in place of glutamic acid at residue 8 of the mature protein and lysine for threonine at residue 12 (see above and Fig. 2B ). These data, cDNA sequence data obtained from the LTBOO16 clone ClS1 (P.J.L. and J. Bock, unpublished data) and vaccination Proc. Natl. Acad. Sci. USA 87 (1990) The differences found between the protein sequence derived from the genomic DNA sequence and that of the isolated protein may be due to potential errors in the protein sequence data or because the GP46/M-2 is encoded by a gene family (see below). In addition, the original protein sequence data were obtained from populations of late logarithmic phase organisms of the L. amazonensis strain LTBOO16, whereas the sequenced genomic clone has been derived from promastigotes of a clone (ClSi). Consequently, further analyses will be required to determine the basis for the variation between the genomic DNA-derived sequence and original protein sequence data.
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Structural Analysis of GP46. Analyses of the primary protein sequence were performed to reveal biochemically important features and to suggest possible protein secondary structures. Three specific areas of amino acid sequence were identified within the GP46/M-2 molecule (Fig. 3) ; these are discussed below.
A Kyte-Doolittle hydropathicity plot (29) 
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boxyl-terminal portions of the molecule. Consensus sequences specific for the cleavage and removal ofhydrophobic leader peptides from membrane-associated proteins (for review, see ref. 30 ) predict a leader peptide for GP46/M-2 that extends for 32 amino acid residues from a methionine (amino acid residue -32) through an alanine (amino acid residue -1, Fig. 4 ) and predicts that the amino terminus of the protein is an alanine, consistent with protein sequence data.
The attachment of glycoproteins to the outer membrane surface through a specific glycolipid linkage has been described for a variety of organisms (31) (32) (33) . Preliminary data (L. Rivas and D.M.-P., unpublished results) have indicated that the mature form of GP46/M-2 contains a carboxylterminal-linked glycolipid that acts to anchor the protein to the parasite surface membrane. Carboxyl-terminal protein sequence data derived from glycolipid-anchor-containing proteins (33) indicates that, after synthesis of the protein is complete, relatively short hydrophobic peptides are removed prior to the addition of a glycolipid tail. Commonly, the two amino acids found immediately after the cleavage site include combinations of alanine, asparagine, aspartic acid, glycine, and serine residues and a hydrophobic sequence of variable length (7- Cys426 to the end of the protein fits the basic criterion for a hydrophobic peptide and a Asp-Gly-Ala amino acid sequence is found upstream at residues 420-422 that could be cleaved between Asp420 and Gly421 with the subsequent attachment of glycosyl-phosphatidylinositol anchor to Asp-420.
Pulse-chase and endoglycosidase experiments characterizing the GP46/M-2 protein (16) suggested the presence of a single asparagine-linked glycosylation site. Nonetheless, a consensus amino acid sequence [Asn-Xaa-Thr or Asn-XaaSer (34)] was not found in the GP46/M-2 protein sequence. However, an Asn-Ala-Cys (34, 35) sequence is present at position Asn-193 (Fig. 2B) ; this exact sequence has been described (34, 35) as aglycosylation site for bovine protein C. The location of the putative GP46/M-2 glycosylation site agrees with data that localizes the carbohydrate to within the 27-kDa carboxyl-terminal segment of the protein (16).
GP46/M-2 Repetitive Sequence. The amino-terminal half of the GP46/M-2 molecule contains a sequence of 24 amino acids that is repeated four times and constitutes nearly a quarter of the total protein sequence. The aligned repeated sequences are indicated in Fig. 2B . The carboxyl-terminal segment of the repetitive sequence appears to be relatively conserved, while there appears to be more variation in the amino-terminal portion. In addition, the type of amino acid (hydrophobic versus hydrophilic) appears to be conserved at certain repeat (16) . In addition, such refractoriness may be essential for the maintenance of the biological function of this molecule for the promastigote as it develops within the hydrolytic environment found in the midgut of the sand fly.
Cysteine residues are generally involved in disulfide bond formation; however, the presence of sequences within this region with the motifs Cys-Xaa-2-4-Cys/His-Xaa,-Cys-Xaa2_ 4-Cys (residues 232-246) and His-Xaa4-Cys (residues 184-189) are suggestive of metal binding proteins (52) . The stability of this segment/domain of the GP46/M-2 molecule, as observed for other molecules, could be due in part to metal ion binding (53) . Alternatively, the cysteine residues in the carboxyl-terminal segment may contribute to stabilization through formation of disulfide bonds (54 Fig. 2A 
CONCLUSIONS
The gene encoding the immunologically protective GP46/ M-2 protein of L. amazonensis has been cloned and sequenced. The DNA sequence data agree with the known biochemical and immunochemical features of the molecule. Southern blot analyses suggest multiple copies or a family of GP46/M-2 genes in L. amazonensis. The amino acid sequence of the protein is distinct from those reported for Leishmania membrane proteins and appears to represent a unique class/family of antigenic surface molecules. The GP46/M-2 molecule has been demonstrated in a murine model system to elicit a protective immune response against infection with L. amazonensis; consequently the ability of the related molecules of other species to elicit protection will be of interest in terms of a future vaccine against leishmaniasis.
